Researchers find commonly used antimalarial drug has better activity against malaria parasites than previously thought.
Can slight variations in lab environments affect the malaria-causing parasite (Plasmodium) and its tolerance to anti-malarial drugs? Griffith University’s Sandra Duffy believes it’s possible.
The fight against malaria has a distinctly personal connection for Uganda-born Aloysious Ssemaganda, who knows the disease only too well. Aloysious has joined Professor Good, from Griffith University’s Institute for Glycomics, in a bid to beat malaria.
When 11-year-old Emma has her mum along to netball games, little do her teammates know that her mum is working to tackle one of the world’s deadliest diseases. Professor Kathy Andrews is a leading biomedical scientist working to save millions of lives by finding new treatments for malaria, but when she leaves the Griffith Institute […]
Griffith University scientists have helped discover new compounds which could help block the transmission of the deadly disease malaria. A team of Griffith researchers has found a novel class of compounds, the hexahydro quinoline (HHQ), with potent activity against the parasite stages responsible for the clinical symptoms of malaria and its transmission to mosquitoes.
A “Malaria Box” that could hold the answer to discovering new drugs to treat tropical diseases and cancer has been created for researchers around the world. Griffith University tropical disease researchers have joined together with a host of international laboratories to advance drug discovery for major topical diseases through the creation and testing of the […]
Griffith University’s Institute for Glycomics will open its doors to the public to showcase its malaria vaccine project.